|MWI Veterinary Supply, Inc.|
3041 West Pasadena Dr.
United States - Map
MWI Veterinary Supply, Inc., together with its subsidiaries, distributes animal health products to veterinarians in the United States and the United Kingdom. The company offers pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, supplies, specialty products, veterinary pet food, capital equipment, and nutritional products. Its pharmaceutical products include anesthetics, analgesics, antibiotics, ophthalmics, and hormones; vaccine products comprise small animal, equine, and production animal biologicals; parasiticides are used for control of fleas, ticks, flies, mosquitoes, and internal parasites; and micro feed ingredients include pharmaceuticals, vitamins, minerals, and other nutritional products that are used to enhance the health and performance of production animals. The companys diagnostics products consist of consumable in-clinic tests for detecting heartworm, lyme, feline leukemia, and parvovirus, as well as consumable products for measuring blood chemistry, electrolyte balance, and cell counts; capital equipment products include anesthesia machines, surgical monitors, diagnostic equipment, dental machines, cages, lights, and X-ray machines; and supplies include syringes, instruments, bandages, IV products, surgical consumables, grooming materials, and other small equipment items used by veterinary practices. Its veterinary pet food products comprise foods for specialty diets and premium pet foods; and nutritional products include dietary supplements, vitamins, dental chews, and specialty treats. The company was formerly known as MWI Holdings, Inc. and changed its name to MWI Veterinary Supply, Inc. in April 2005. MWI Veterinary Supply, Inc. was founded in 1976 and is headquartered in Boise, Idaho.
|MWI Veterinary Supply, Inc.’s ISS Governance QuickScore as of Jan 1, 2015 is 3. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 5; Compensation: 3.|
|Brought to you by Institutional Shareholder Services (ISS)|
|Mr. James F. Cleary Jr.,
Chief Exec. Officer, Pres, Director and Member of Fin. Committee
|Ms. Mary Patricia B. Thompson CPA,
Chief Financial Officer, Principal Accounting Officer and Sr. VP of Fin. & Admin.
|Mr. Jeremy C. Ouchley ,
VP and Gen. Counsel
|Mr. Jeffrey J. Danielson ,
VP of Sales
|Mr. John J. Francis ,
VP and Gen. Mang. of Specialty Resources Group
|Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|